Acute Migraine Treatment Guideline
Authors: Vincenza Snow
Journal: Annals of Internal Medicine (2003)

Letters7 October 2003Acute Migraine Treatment GuidelineVincenza Snow, MDVincenza Snow, MDFrom the American College of Physicians; Philadelphia, PA 19106.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-139-7-200310070-00026 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail IN RESPONSE:Dr. Marino provides a very interesting account of her journey toward achieving relief from her migraines. Happily, she has found a preventive therapy that is effective for her. Dr. Marino cites several reports on the use of botulinum toxin therapy in migraine headache and asks why it was not included in the evidence review for the American College of Physicians guidelines. First, I must point out that the College's guideline is based on an exhaustive systematic review of the evidence, performed under the auspices of U.S. Headache Consortium (1, 2). These evidence reviews covered published studies up until ...References1. Matchar DB, Young WB, Rosenberg JH, Pietrzak MP, Silberstein SD, et al. Evidence-based guidelines for migraine headache in the primary care setting: pharmacological management of acute attacks. 2000. Available at www.aan.com/professionals/practice/guidelines.cfm Google Scholar2. Ramadan NM, Silberstein SD, Freitag FG, Gilbert TT, Frishberg BM. Evidence-based guidelines for migraine headache in the primary care setting: pharmacological management for prevention of migraine. 2000. Available at www.aan.com/professionals/practice/guidelines.cfm Google Scholar3. McCrory DC, Matchar DB, Gray RN, Rosenberg JH, Silberstein SD. Evidence-based guidelines for migraine headache: overview of program description and methodology. 2000. Available at www.aan.com/professionals/practice/pdfs/gl0086.pdf. Google Scholar4. Binder WJ, Brin MF, Blitzer A, Schoenrock LD, Pogoda JM. Botulinum toxin type A (BOTOX) for treatment of migraine headaches: an open-label study. Otolaryngol Head Neck Surg. 2000;123:669-76. [PMID: 11112955] CrossrefMedlineGoogle Scholar5. Silberstein S, Mathew N, Saper J, Jenkins S; the Botox Migraine Clinical Research Group. Botulinum toxin type A as a migraine preventive treatment. Headache. 2000;40:445-50. CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAuthors: Vincenza Snow, MDAffiliations: From the American College of Physicians; Philadelphia, PA 19106. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoPharmacologic Management of Acute Attacks of Migraine and Prevention of Migraine Headache Vincenza Snow , Kevin Weiss , Eric M. Wall , and Christel Mottur-Pilson , for the American Academy of Family Physicians and the American College of Physicians–American Society of Internal Medicine*Acute Migraine Treatment Guideline Catherine Marino Metrics 7 October 2003Volume 139, Issue 7Page: 603-604KeywordsBotulinum toxinHeadachesMigrainePreventive medicineSafetySafety studiesSystematic reviewsTreatment guidelines ePublished: 7 October 2003 Issue Published: 7 October 2003 Copyright & PermissionsCopyright © 2003 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...